Supplements for joint health

Compared by effect and evidence certainty. Cost is not currently assessed, and nothing here is sold to you.

Omega-3grade Bmoderate certainty— reduces joint tenderness / morning stiffness in rheumatoid arthritis

Safety: serious — High-dose omega-3 with warfarin may increase bleeding risk.. Cost: not assessed. Evidence gaps: no major structured gap flagged; review the claim limitations.

Glucosaminegrade Clow certainty— small and inconsistent osteoarthritis benefit; large independent trials disappointed

Safety: no modeled interaction found; coverage unknown, not proven safe. Cost: not assessed. Evidence gaps: studied dose not reported; population bounds not reported; certainty or evidence strength remains limited.

Collagengrade Clow certainty— limited evidence for joint comfort in athletes

Turmericgrade Clow certainty— modest, short-term pain relief in osteoarthritis in small studies

Safety: moderate — High-dose curcumin may have mild antiplatelet effects; caution with warfarin.. Cost: not assessed. Evidence gaps: studied dose not reported; population bounds not reported; certainty or evidence strength remains limited.

Vitamin Dgrade Clow certainty— Meta-analysis of 4 high-quality RCTs (1130 participants): vitamin D supplementation had a statistically significant but small-to-moderate effect on pain reduction in knee osteoarthritis, but showed no effect on tibial cartilage volume — a pain-relief signal without evidence of structural (disease-modifying) benefit.

Safety: minor — Magnesium is a cofactor in vitamin D metabolism; the two are complementary.. Cost: not assessed. Evidence gaps: certainty or evidence strength remains limited.

Creatinegrade Dvery-low certainty— Narrative review of creatine plus resistance training for knee osteoarthritis: available studies suggest positive effects with no significant adverse events, but sample sizes are very small and results vary between studies. Not enough evidence to establish a real effect yet.

Safety: no modeled interaction found; coverage unknown, not proven safe. Cost: not assessed. Evidence gaps: certainty or evidence strength remains limited.

Ginkgograde Dvery-low certainty— Narrative review: Ginkgo biloba extract (EGb 761) has demonstrated anti-inflammatory, antioxidant, and chondroprotective properties in experimental and preliminary clinical research for knee osteoarthritis, but this is a synthesis of mechanistic and early findings, not a meta-analysis of controlled trial outcomes. Too preliminary for a confident effect estimate.

Safety: serious — Ginkgo has antiplatelet activity; with warfarin it may increase bleeding risk.. Cost: not assessed. Evidence gaps: certainty or evidence strength remains limited.